Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anju Sahdev

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Clinical Endocrinology|November 27, 2013
Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous samplingW C Candy Sze, Lip Min Soh, Jeshen H Lau, et al.
JAMA Oncology|June 3, 2016
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal CancerThomas Powles, Naveed Sarwar, Andrew Stockdale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical CarcinomaAndrea G Rockall, Tara D Barwick, William Wilson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2025
Diagnostic performance of quantitative measures from [<sup>18</sup>F]FDG PET/CT, [<sup>18</sup>F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING studyBen G King, Nishat Bharwani, William Wilson, et al.
BJUI Compass|October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testingEoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
Frontiers in Oncology|July 5, 2022
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaLeonardo Rundo, Lucian Beer, Lorena Escudero Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2013
The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancerKevin Sharpe, Grant D Stewart, Alan Mackay, et al.
Nature Communications|October 24, 2023
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancerMireia Crispin-Ortuzar, Ramona Woitek, Marika A V Reinius, et al.
European Radiology Experimental|December 6, 2023
Deep learning-based segmentation of multisite disease in ovarian cancerThomas Buddenkotte, Leonardo Rundo, Ramona Woitek, et al.
Nature Medicine|January 16, 2023
[<sup>11</sup>C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trialXilin Wu, Russell Senanayake, Emily Goodchild, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Clinical Endocrinology|November 27, 2013
Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous samplingW C Candy Sze, Lip Min Soh, Jeshen H Lau, et al.
JAMA Oncology|June 3, 2016
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal CancerThomas Powles, Naveed Sarwar, Andrew Stockdale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical CarcinomaAndrea G Rockall, Tara D Barwick, William Wilson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2025
Diagnostic performance of quantitative measures from [<sup>18</sup>F]FDG PET/CT, [<sup>18</sup>F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING studyBen G King, Nishat Bharwani, William Wilson, et al.
BJUI Compass|October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testingEoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
Frontiers in Oncology|July 5, 2022
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaLeonardo Rundo, Lucian Beer, Lorena Escudero Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2013
The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancerKevin Sharpe, Grant D Stewart, Alan Mackay, et al.
Nature Communications|October 24, 2023
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancerMireia Crispin-Ortuzar, Ramona Woitek, Marika A V Reinius, et al.
European Radiology Experimental|December 6, 2023
Deep learning-based segmentation of multisite disease in ovarian cancerThomas Buddenkotte, Leonardo Rundo, Ramona Woitek, et al.
Nature Medicine|January 16, 2023
[<sup>11</sup>C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trialXilin Wu, Russell Senanayake, Emily Goodchild, et al.
Pageof 8